Valuation: Ovation Science Inc.

Market Cap 1.15M 812K 717K 678K 615K 77.95M 1.16M 8.14M 3.14M 39.8M 3.05M 2.98M 128M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 961K 848K 802K 728K 92.19M 1.38M 9.62M 3.71M 47.08M 3.61M 3.53M 151M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
3 months+100.00%
Current year-25.00%
1 month 0.02
Extreme 0.02
0.03
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.11
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 29/10/2023
Chief Executive Officer 77 03/10/2017
Director TitleAgeSince
Director/Board Member 77 03/10/2017
Director/Board Member 63 03/10/2017
Director/Board Member 86 01/02/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/04/25 Buy

Director

100,000 0.2642%
31/01/25 Other

Director

0 0%
31/01/25 Buy

Director

100,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%0.00%-14.29%0.00% 814K
-1.10%-2.25%+4.30%-3.17% 233B
+2.38%+2.85%+22.49% - 45.42B
-1.63%-0.96%+61.11% - 10.14B
-0.82%-4.10%+35.11%-35.16% 8.95B
0.00%-1.59%+16.58%+16.97% 6.45B
-0.10%-0.41%-22.48%-7.40% 6.01B
-2.42%-2.71%+14.81%-14.33% 3.78B
-1.28%-5.12%-33.63%-46.87% 3.19B
-0.20%-2.26%+11.49%-26.96% 3.02B
Average +4.25%-0.39%+9.55%-14.62% 32B
Weighted average by Cap. -0.65%+0.32%+9.10%-4.81%

Financials

2024 2025
Net sales 113K 79.75K 70.38K 66.59K 60.39K 7.65M 114K 799K 308K 3.91M 299K 293K 12.57M 67.89K 47.82K 42.2K 39.93K 36.21K 4.59M 68.56K 479K 185K 2.34M 180K 176K 7.54M
Net income -456K -321K -284K -268K -243K -30.83M -461K -3.22M -1.24M -15.75M -1.21M -1.18M -50.67M -631K -445K -392K -371K -337K -42.67M -637K -4.45M -1.72M -21.79M -1.67M -1.63M -70.11M
Net Debt 265K 187K 165K 156K 141K 17.92M 268K 1.87M 721K 9.15M 701K 686K 29.45M 211K 148K 131K 124K 112K 14.25M 213K 1.49M 573K 7.27M 557K 545K 23.41M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. OVAT Stock